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GENERAL INTRODUCTION 
Respiratory syncytial virus (RSV) has been recognized as an impor-
tant respiratory tract pathogen of humans (1-4) and several animal 
species in natural and experimental infection (5-9). 
Following RSV outbreaks, some investigators could easily demon-
strate a significant 4-fold rise in serum antibody titers (10, 11). 
However, one study (12) reported no seroconversion in cattle with 
clinical disease. 
Smith et al. (8) studied a limited number of ovine sera and found 
RSV antibodies. A serological study in Canada (13) indicated that not 
only cattle (14%) but also sheep (81%) and horses (6%) have complement 
fixing antibody titers to RSV. Recently RSV has been isolated from an 
adult sheep with mild rhinitis (14). 
The objectives of this study were to 1) investigate the serum and 
secretory antibody response following RSV inoculation of lambs, 2) 
determine if reexposure to the same virus increases RSV antibody titers, 
and 3) compare the enzyme-linked immunosorbent assay (ELISA) results to 
the indirect fluorescent antibody test (IFA) results in sera and nasal 
secretions. 
This thesis is presented in alternate format which includes one 
manuscript to be submitted to the American Journal of Veterinary 
Research in the style required. References cited in the manuscript are 
included with it in journal format. A general introduction, objectives 
of the study and a literature review precede the manuscript. Additional 
literature cited refers to citations in the general introduction and 
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literature review and is listed in the jourrial format. Acknowledgements 
follow the additional literature cited. The M.S. candidate, Fatima 
Esposti Cabanillas, ·was the principal investigator of the study and is 
the senior author of the manuscript. She also performed all of the 
experimental procedures which are reported in the manuscript with 
limited involvement of the co-authors. 
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LITERATURE REVIEW 
Respiratory Syncytial Virus 
Historical aspects In 1956, Morris, Blount and Savage (15) 
described the isolation of an agent suspected of causing respiratory 
disease in chimpanzees. Because of the production of coryza in these 
animals, they termed the virus: the chimpanzee coryza agent (CCA). 
This isolate was unrelated to other viruses of importance at that time. 
In 1957, Chanock, Roizman and Myers (16) isolated two agents very 
similar to the CCA from infants ·with severe respiratory disease. The 
production of syncytia in the KB strains of human epidermoid carcinoma 
and human liver cells was characteristic of both the human isolates and 
the CCA. 
Further studies using complement fixation and cross-neutralization 
tests showed a very close antigenic relationship between the human 
agents and CCA. Due to their antigenic similarities they were grouped 
together and given the name respiratory syncytial virus (RSV) because of 
their association with the respiratory tract and the production of 
syncytia in vitro (16). 
In 1968, Doggett et al. (17) reported the presence of neutralizing 
antibody against the human RSV in bovine sera. They speculated that 
there was an antigenically similar virus present in cattle. 
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In 1970, Paccaud and Jacquier (11) reported the isolation of a 
virus from cattle during an outbreak of respiratory disease. This virus 
. had a syncytia-f orming effect in embryonic calf kidney (ECK) and 
embryonic calf lung (ECL) cell cultures and was non-hemagglutinating or 
hemadsorbing. 
Cross-neutralization and complement-fixation tests confirmed a 
close antigenic relationship between this bovine isolate and human RSV. 
Subsequently, bovine respiratory syncytial virus (BRSV) has been iso-
lated from cattle with respiratory disease in Japan (18), Belgium (19), 
England (20), and the United States (8) as well as many other countries. 
More recently, RSV has been isolated from goats (21) and sheep (14) with 
respiratory tract disease. Antibodies to RSV have been demonstrated in 
cats, dogs, horses, pigs and several non-human primates, but as yet 
virus has not been isolated from these species (13, 17, 22-24). 
The RSVs are members of the genus Pneumovirus of the 
Paramyxoviridae family (25, 26). As indicated, the virus produces 
syncytia (multinucleate protoplasmic masses) both in cell culture and 
tissue of infected animals and these syncytia contain eosinophilic 
inclusions. The virions of RSV are highly pleomorphic and contain 
single-stranded RNA. The roughly spherical virions are 80 to 500 nm in 
diameter and the filamentous forms are 60 to 110 nm in diameter and may 
be up to 5 µm in length. The envelope contains surface projections that 
are 10 to 12 nm long and spaced 8 to 12 nm. The nucleocapsid symmetry 
is helical and is 12 to 15 nm in diameter. The virus is sensitive to 
lipid solvents, heat, and acid (pH 3.0). No neuraminidase or other 
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enzyme has been described for the Pneumovirus genus. Unlike the 
pneumonia virus of mice which is the other member of the genus, RSV does 
not contain hemagglutinin. 
The most striking characteristic of RSV when it replicates in cell 
culture is the formation of syncytial masses. Syncytia usually have the 
nuclei clustered centrally. Cytoplasmic inclusions surrounded by a 
clear halo can be seen after staining with Giemsa's or hematoxylin-
eosin (27, 28). Armstrong et al. (29) observed multinucleated cells as 
early as 24 hours after inoc~lation with the Long strain of human RSV in 
Hela cell culture and at 48 ·hours the syncytia were large and numerous. 
Jordan (30) studied the replication characteristics of RSV using various 
cell types and media and found that the virus capacity to produce 
syncytia was related to the composition of the medium and to the cell 
type used. Bennet and Hamre (27) and Norrby et al. (31) also reported 
the importance of the cell type used in the degree to which syncytia 
occur. No major nuclear change was reported in a study by Norrby et al. 
(31) but some cells had chromatin margination. Accumulation of glycogen 
and compact inclusions with a granular to "thread-like" composition was 
observed in the cytoplasm (31). 
Armstrong et al. (29) using Hela cell cultures to study the 
inclusions of the ultrastructural level found the cytoplasmic inclusions 
to be of two types. The first one.was small and paranuclear with a fine 
fibrillar matrix; the other was bigger, widely distributed in the cyto-
plasm and had a dense amorphous or granular matrix. Syncytia had both 
types of inclusions but mononuclear cells had only the fibrillar type. 
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Another characteristic of RSV is that it is extremely labile and 
this makes virus isolation from frozen samples difficult (32). Rambling 
(33) studied the stability of the virus using variable temperatures and 
serum concentrations and observed that using the lowest practical 
temperature (-65° C) and avoidance of refreezing resulted in the highest 
infectivity for a long period of time. Using more than 5 percent of 
serum did not result in improvement of virus survival time. It was also 
shown that it is possible to lose virus infectivity even at low 
temperatures. Virus stored at -65° C during three months had a 50 
percent decrease in infectivity. 
Clinical signs, pathogenesis and pathology Antibody to RSV is 
widespread in the human population (2, 34, 35). The virus is considered 
to be the major cause of bronchiolitis and pneumonia in infants and 
young children and is the leading cause of fatal respiratory tract 
disease in children less than a year old (9, 36). In older children and 
adults, the infection is primarily upper respiratory tract and produces 
symptoms similar to those of the common cold caused by other viruses. 
Reinfection is common in older children and adults with clinical 
response to subsequent infections less than that of the primary 
infection (37). 
The mechanism by which RSV produces the most severe disease mani-
festations, which usually occur during the first few months of life, is 
unknown. An interesting feature is that serious disease from RSV 
infection occurs in these inf ants in the presence of circulating anti-
body, indicating that passive immunity is not protective (36, 38, 39). 
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The role of cell-mediated immunity in the pathogenesis of RSV infection 
is also unknown (9, 39-41). Several investigators believe that anti-
bodies may be associated with allergic reactions in the lung and exacer-
bate the disease in infants and children (42-46). However, in a recent 
review by Mcintosh and Fishant (39), they state that "no firm conclu-
sions are, possible about immunopathologic mechanisms." 
The clinical and pathologic response of RSV infections in cattle 
has been extensively studied also. This has been through observations 
of natural infections and experimental infectivity studies. The isola-
tion of RSV from cattle has been associated with mild to acute respira-
tory tract disease (6, 8, 10-12, 18-20, 47, 48). The disease in cattle 
is characterized by anorexia, depression, pyrexia, respiratory distress, 
cough, nasopharyngeal secretions and lacrimation. Cattle with fatal 
infections often show emphysema, edema and consolidation of the lungs. 
Experimental infectivity studies in cattle have not resulted in a 
response similar to that thought to occur naturally (5, 8, 19, 49-52) 
although studies by Bryson et al. (53) have come close. Smith et al. 
(8) and Wellemans and Leunen (54) described a more serious illness in 
those calves with circulating antibody to RSV prior to experimental 
infection. Whether or not there is an immune mediated component to RSV 
infection in cattle is speculative. 
Experimental infectivity studies in other species indicated that 
ferrets, mink, chinchillas, guinea pigs, AKR mice, cotton rats and 
white-lipped marmosets were susceptible to infection with human RSV but 
did not develop clinical signs of disease (55-57). A rise in RSV 
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antibody titer in swine sera occurred with several disease problems 
suggesting that an as yet unisolated virus antigenically similar to RSV 
may be present and pathogenic for swine (24). Lambs can be infected 
experimentally with bovine RSV (58, 59) and recently RSV was isolated 
from an adult sheep with mild rhinitis (14). A RSV has been isolated 
from goats during an outbreak of acute respiratory tract disease (21). 
The significance of RSV in naturally occurring respiratory tract disease 
in sheep and goats has not been determined. 
Serology Serologic means are usually used to diagnose RSV 
infection (32) because virus isolation is frequently unsuccessful (8, 
12, 32, 54). Serologic diagnosis of RSV infection can be made by 
comparison of antibody titers of acute and convalescent serum samples. 
Tests used for the detection of RSV antibody in cattle, sheep, and goats 
include serum virus-neutralization (SVN) (6-8, 32), complement-fixation 
(CF) (60), immunodiffusion (ID) (61), indirect fluorescent antibody 
(IFA) (62), enzyme-linked immunosorbent assay (ELISA) (63), and indirect 
hemagglutination (IHA) (64). 
While some form of the SVN test is the most frequently used for RSV 
serology, it is not without problems. The SVN test requires at least 5 
days before the results can be read and it is difficult to determine an 
endpoint because complete neutralization of RSV is rarely achieved. The 
search for a more sensitive and reproducible SVN test for antibody to 
RSV resulted in the plaque-reduction SVN test (8, 65-70). 
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Indirect fluorescent antibody test is another test that has been 
extensively used to detect RSV antibody (28, 32, 38, 50, 62, 71). 
Potgieter· and Aldridge found the IFA test to be simple to perform and 
more rapid and sensitive than the microtiter SVN test (62). In addi-
tion, they felt that it was as sensitive as the plaque-reduction SVN 
test. 
The more recent development of an ELISA test for the detection of 
RSV antibodies shows promise (63, 72-74). Richardson et al. (73) found 
the ELISA test to be more sensitive, specific and reproducible than the 
CF and plaque-reduction SVN tests. Gillette (63) found that the ELISA 
te~t compared favorably with the plaque-reduction SVN and better than 
the CF test. The ELISA offers the advantage of being sensitive, rapid, 
and reproducible, and can be performed on minute amounts of serum (75, 
76). 
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STUDY OF THE ANTIBODY RESPONSE IN SHEEP TO RESPIRATORY 
SYNCYTIAL VIRUS USING AN ENZYME-LINKED IMMUNOSORBENT ASSAY 
AND INDIRECT FLUORESCENT ANTIBODY TESTS 
This manuscript will be submitted to the American Journal of 
Veterinary Research. 
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STUDY OF THE ANTIBODY RESPONSE IN SHEEP TO RESPIRATORY 
. 
SYNCYTIAL VIRUS USING AN ENZYME-LINKED IMMUNOSORBENT ASSAY 
AND INDIRECT FLUORESCENT ANTIBODY TESTS 
Summary 
The antibody response to respiratory syncytial virus (RSV) in lambs 
was followed using an enzyme-linked immunosorbent assay (ELISA) and 
indirect fluorescent antibody (IFA) test. Two groups of isolation-
reared lambs were exposed transtracheally and intranasally to a bovine 
isolate of RSV; one group of 5 lambs three times and the other group of 
5 lambs one time. The antibody response in serum and nasal secretions 
was followed weekly for 22 weeks. 
After the initial exposure to RSV, the geometric mean titer (GMT) 
of the serum antibody rose 32.5 and 8.4-fold when assayed by the ELISA 
and IFA tests respectively. With the second exposure, there was a 
19.7-fold rise in the GMT by the ELISA test and a 4.9-fold rise in the 
GMT by the IFA test. The third exposure resulted in a 3-fold rise in 
GMT to RSV with both tests. The ELISA test gave an earlier 4-fold rise 
in GMT after the second exposure to RSV than did the IFA test. 
After the initial inoculation, nasal secretions were negative for 
antibodies in both tests. The group that received second and third 
exposures became positive in both tests after the second exposure. 
No clinical signs of illness were observed after RSV inoculation 
and virus was not isolated from the lambs. 
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Introduction 
Both complement-fixing antibody and neutralizing antibody to 
respiratory syncytial virus (RSV), a known respiratory tract pathogen, 
have been found in sheep serum (1-3) and recently RSV was isolated from 
an adult sheep with mild rhinitis (4). These findings alon~ with 
results of experimental infectivity studies using bovine strains of RSV 
indicate involvement of RSV in respiratory tract disease of sheep (5-7). 
The objectives of this study were to investigate the serum and 
secretory antibody response after exposure to respiratory syncytial 
virus, to compare the sensitivity of the ELISA and !FA tests, and to 
quantify the levels of serum antibody response after single vs. multiple 
exposures to RSV. 
Materials and Methods 
Experimental design Ten 4-week-old lambs were used in this 
study. The animals were reared in isolation and divided into two groups 
at week 10 post-inoculation. Group 1 composed of 5 lambs was given one 
dose of inoculum intratracheally and intranasally at the beginning of 
the experiment (week 0). Group 2 was given three doses of inoculum 
intratracheally and intranasally at weeks 0, 10 and 16. 
Sera and nasal secretions were collected at weekly intervals 
beginning the day of inoculation with RSV, continuing for a period of 22 
weeks after inoculation. Antibody titers to RSV were determined using 
an ELISA technique and an !FA test. 
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Following each inoculation, lambs were observed daily for clinical 
signs of illness and their rectal temperatures recorded for 9 days. 
Nasal swabs were taken for viral isolation on the day of inoculation, 
then daily for 9 days. 
Cell culture Ovine fetal turbinate (OFTU) cells were grown as 
described by Lehmkuhl and Cutlip (5). Briefly, cells were grown as 
monolayers in Eagle's minimal essential medium (EMEM) supplemented with 
5% fetal calf serum, gentamicin sulfate (50 µg/ml) and L-glutamine. 
Cell cultures were incubated at 3~° C in a 5% co2 atmosphere. 
Virus Seventh laboratory passage of strain 375 of RSV which had 
been isolated from calves with acute respiratory tract disease was used 
{8). 
Inoculum The virus was grown in OFTU cells until approximately 
80% of the cells showed cytopathic effects (CPE). The cultures were 
then frozen and thawed. This tissue culture fluid was frozen at -70° C 
until needed for inoculation. Each lamb was inoculated with 15 ml of 
tissue culture fluid intratracheally and 5 ml intranasally. The 
inoculum contained 104 plaque-forming units per ml. 
Specimens for serology Serum samples were prepared and nasal 
secretions were collected once a week from the day of inoculation 
through 22 weeks post-inoculation. Nasal secretions were collected with 
sterile cotton balls on hemostats which .were inserted into the nostril 
and held there for approximately 2 minutes. The cotton balls were 
placed in sterile bottles containing 2 ml of cell-culture medium. The 
fluid was expressed from the cotton ball by using a 10 ml syringe and 
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the fluid was stored at -70° C. Before use, the nasal secretions were 
thawed and centrifuged at 8320 xg in a Microfuge 12a for 2 minutes and 
the supernatant was used ·in the ELISA and IFA tests. 
ELISA antigen preparation Three different RSV antigens were 
used in preliminary ELISA tests; a crude antigen prepared directly from 
infected tissue culture, a semi-crude antigen obtained after precipita-
. o , 
tion with (NH4) 2so4 and an antigen prepared as reported by Bruckova et 
al. (9). 
ELISA test The method used was that described by Voller et al. 
(10) with the modifications of Gillette (11) for the preparation of 
buffers, substrate and solutions. The test was done in flat-bottom 
microELISA plates.b Optimal dilutions of conjugatec and viral antigen 
were determined according to the method of Snyder and Erickson (12). 
Diluent, negative serum, and weak and strong positive sera at 1:20 
dilution were included in each plate. The strong positive serum had a 
titer by the plaque-reduction test ~l,024; weak positive serum between 8 
and 32; and negative serum <4. Correction for plate to plate variations 
was made by using the ratio of the average of all reference negative 
serum readings during the experiment and the reference negative serum 
reading of each plate. 
a 
Beckman Instruments, Inc., Palo Alto, CA. 
b 
Immulon 2 plates, Dynatech Laboratories, Inc., Alexandria, VA. 
c 
Peroxidase conjugated IgG Fraction Rabbit Anti-Sheep IgG (heavy 
and light chains), Cappel Laboratories, Cochranville, PA. 
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Duplicate samples of serial two-fold dilutions were made with serum 
samples starting with a 1:20 dilution. Nasal secretions were diluted 
1:20. Plates were read on an ELISA reader8 at A ratio of 405/450 nm. 
Using the method of Hornsleth et al. (13), samples with absorbance 
values >0.112 were positive. 
!FA test The method was modified from the procedure of 
Potgieter and Aldridge (14). 
Strain 375 of bovine RSV was inoculated into OFTU cells and allowed 
to replicate until CPE was seen in approximately 50% of the monolayer. 
The cells were then trypsinized, resuspended in EMEM supplemented with 
5% BFS, and dropped onto 8-well heavy teflon coated (HTC) microscope 
slidesb using a 50 µl microtiter dropper. The slides were incubated in 
a humid co2 incubator until the cells attached to the surface, then air 
dried and fixed in cold acetone for 5 minutes. The slides were placed 
in slide boxes and stored at -70° C until they were used. 
Serial dilutions of serum samples starting from 1:2 were used to 
determine dilution extinction endpoints. Nasal secretions were tested 
without any further dilution than that following sampling. A commercial 
rabbit anti-sheep immunoglobulin G conjugated with fluorescein 
isothiocyanatec was'used for antibody detection. 
~ynatech MR-580, Dynatech Laboratories, Inc., Alexandria, VA. 
bCel-Line Associates, Inc., Newfield, NJ. 
cMiles Laboratory, Inc., Research Division, Elkhart, IN. 
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Viral isolation Nasal secretions collected with cotton swabs 
were used for RSV isolation attempts. The procedure used was that 
described by Lehmkuhl and 'Cutlip (5) except OFTU cells were used. 
Results 
ELISA test Experiments to evaluate the ELISA antigens showed 
that neither crude antigen nor semi-crude antigen were appropriate for 
this study due to their high background reaction (Fig. 1). Antigen 
prepared using the method of ·Br~ckova et al. (9) was the most suitable. 
This antigen (optimal dilution 1:400) showed a greater difference 
between the absorbance reading of the positive control serum and the 
negative control serum. It also gave a minimum background reaction as 
proved by the low absorbance reading corresponding to the diluent 
control (PBS). 
Because the control antigen reacted very weakly with reference sera 
in several preliminary tests; all serum samples from week 5 were 
absorbed with OFTU cells and the absorbed and unabsorbed serum tested 
against the control antigen. No difference was seen in the absorbance 
readings indicating no participation of cellular antigens in the 
production of the humoral response. 
During the standardization of the ELISA test, non-specific 
reactions were observed on several occasions. Those reactions were 
suspected to be due to the use of tape to cover the microElisa plates 
during the incubation period. Comparison studies between tape and 
paraf ilm confirmed that idea and showed that paraf ilm was the better 
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choice. Parafilm gave more consistent absorbance readings of ELISA 
controls and also minimum non-specific reactions. 
Preinoculation sera collected at the beginning of the experiment 
.had titers of 20 or 40 (GMT 32). 
Following the first inoculation with RSV, Groups 1 and 2 were 
treated as a single group up to week 10. Extrapolating from the plot of 
the GMT of the serum antibody to RSV (Fig. 2), a four-fold rise in GMT 
was produced by day 10 postinoculation. After the second week, titers 
)160 were observed with the peak titers at week 7. There was a 
32.5-fold rise in GMT between weeks 0 and 7. By the end of the first 
observation period, however, there was a slight decrease (2.3-fold 
between weeks 7 and 9) in the GMT. The serum antibody levels in Group 1 
·lambs remained relatively constant from week 10 through week 22. The 
GMT fluctuated from 422 to 735 and the titer range was from 320 to 1280. 
The second inoculation of RSV in Group 2, 10 weeks after.the first, 
resulted in a quicker response than that observed with the primary 
challenge. From the curve, a four-fold rise in GMT was reached by day 4 
PI. One week after the second exposure, the titer of all 5 lambs was 
5120. There was a 19.7-fold rise in GMT three weeks after the second 
exposure. 
With the third inoculation of Group 2 with RSV at 16 weeks, the 
maximal GMT reached was 13,512. This occurred 2 weeks after the 
inoculation and was only a three-fold rise. There was a four-fold 
decrease in GMT between weeks 19 and 22. 
18 
Nasal secretions which were tested for RSV antibody only at 1:20 
dilution were negative from the beginning of the study through week 10. 
Following the second inoculation of Group 2 with RSV, the nasal 
secretions became positive for RSV antibody and remained so through the 
22 weeks of the study. 
IFA test At week 0, the GMT to RSV by the IFA test was 10. As 
with the ELISA test, the lambs were treated as a single group up to week 
10. There was a four-fold rise in GMT 11 days following the first 
inoculation of the lambs with RSV (Fig. 3). There was an 8.4-fold rise 
in the IFA GMT by week 3 postinoculation. The GMT of Groups 1 and 2 
were relatively constant from week 3 through week 10 at which time 
Group 2 received the second inoculation of RSV. The response of Gr~up 1 
remained relatively constant at a GMT of 56 ~o 60 through the 22 weeks 
of the study. There was less than a two-fold decrease in GMT from 
week 3 to week 22. 
The second inoculation of Group 2 resulted in a four-fold rise in 
GMT by day 7 PI. The maximum GMT (294) was observed 2 weeks after the 
second exposure. This was a 4.9-fold rise in IFA GMT. As with the 
first exposure, there was less than a two-fold decrease in GMT from week 
12 to week 16. 
Following the third inoculation of Group 2, the maximum rise in GMT 
was three-fold. This occurred week 18, 2 weeks after inoculation. The 
GMT at that time was·776. There was less than a two-fold decrease in 
GMT from week 18 to week 22. 
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The results of the IFA test for the nasal secretions were the same 
. 
as with the ELISA test. The lambs of Group 1 were negative· for RSV 
antibody during the 22 weeks of the study as where the lambs of Group 2 
became positive following the second inoculation of RSV. 
Virus isolation and clinical response Attempts to isolate RSV 
from all lambs were unsuccessful. The lambs did not develop clinical 
signs of infection following inoculation and the rectal temperature 
remained normal. 
Discussion 
The presence of low antibody titers to RSV previous to the first 
inoculation could be due to maternal antibodies passively transferred 
via colostrum to· these lambs. 
All lambs in the experiment developed an antibody response 
following RSV inoculation. Serum results with both testing procedures 
after first inoculation were similar in several aspects. First, both 
tests detected a four-fold rise in antibody titer at the same time. 
Second, both tests detected the stabilization of maximum antibody titers 
at the same time. Finally, the antibody response curves of both tests 
have the same shape. The difference between the results with both 
techniques was that ELISA titers rise were four-fold higher than those 
with IFA. 
The IFA results in serum after first inoculation agree with those 
reported by El Azhary et al. (15). 
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Second and third exposures to RSV did result in an increase in 
antibody titers (that was monitored by both procedures) confirming the 
idea that·sheep are susceptible to reinfection. This finding is in · 
agreement with that of Mohanty et al. in cattle (16). 
After each inoculation, antibody titers in serum were notably 
increased and then remained high as long as the experiment allowed. The 
same kind of response, but in calves, has been reported by El Azhary et 
al. (17). 
Following second exposure of lambs to RSV, ELISA detected a 
four-fold rise in antibody titer earlier and had a mean rise in antibody 
titer four-fold higher than IFA. This observation, together with the 
fact that ELISA titers were higher than IFA titers after the first 
exposure, led to.the conclusion that ELISA is more sensitive than IFA 
for detecting the serologic response of lambs to RSV. After the third 
exposure, both tests had identical results measuring antibody rise and 
time of maximum antibody stabilization may be because both tests were 
unable to detect minimal changes in antibody titers at such high 
dilutions. The high sensitivity of the ELISA has been previously 
reported (9, 18, 19). In addition, ELISA was found more efficient than 
IFA for detection of early RSV antibody. 
In nasal secretions both testing procedures failed to detect an 
antibody response following a single exposure, perhaps due to the 
dilution of the samples or because the antigen dose was not enough to 
produce a primary response. Lehmkuhl and Cutlip (5) speculated that 
replication of RSV does not occur in the upper respiratory tract, thus 
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not stimulating a local immune response in the sheep following one 
exposure. On the other hand, second and third challenges gave increased 
antibody titers which were ·detected by both tests. These observations 
are compatible with those previously reported by Wellemans et al. (20). 
As reported by Brfickova et al. (9), we also found that ELISA is 
able to detect long-persisting antibodies. In our study, the 
sensitivity of the method persisted up to 5 months following a single 
inoculation. 
Another advantage of the ELISA as ~lready reported by Steinhoff et 
al. (21) is that its results are numerical and that makes possible the 
use of statistical methods to determine the degree of positivity of the 
samples. Consequently, the results of the ELISA are more reliable and 
objective. 
The indirect fluorescent antibody test was easier and faster to 
perform compared to the ELISA test. The IFA presents the following 
disadvantages: non-specific fluorescence and subjective results. 
Non-specific fluorescence can be reduced by dilution of the conjugate as 
previously reported (22). We used a 1:16 dilution of the conjugate that 
gave minimal background and high specific fluorescence. 
Our failure to demonstrate a clinical illness following RSV 
inoculation is in agreement with a previous report (2) that described 
RSV seroconversions in lambs without any clin~cal signs. 
Isolation attempts to recover RSV from nasal secretion were 
negative, confirming the great !ability of the virus and the difficulty 
of its isolation (8, 23). 
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In summary, we have monitored a serum antibody response to both a 
single and multiple RSV inoculation and found increased antibody titers 
following second and third exposure. In nasal secretions we were able 
to detect antibody only after re-exposure to the virus. Both ELISA and 
IFA tests had a satisfactory performance with ELISA slightly more 
sensitive and efficient at detecting early and long-persisting 
antibodies to RSV infection. 
Fig. 1. 
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Comparison of absorbance values obtained for three different 
respiratory syncytial virus antigens. Ag #1 Crude antigen 
prepared directly from infected tissue culture fluid. Ag #2 
Purified antigen prepared as reported by· Brftckova et al. (9) 
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